Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological aspects of epilepsy

J A Aarli1

  • 1Department of Neurology, University of Bergen, Haukeland Hospital, Norway.

Brain & Development
|January 1, 1993
PubMed
Summary

Systemic lupus erythematosus (SLE) patients may develop seizures, sometimes linked to anti-epileptic drug treatment. A genetic predisposition may underlie both epilepsy and SLE, potentially involving immune system disturbances like IgA deficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin.

European journal of neurology·2013
Same author

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.

European journal of neurology·2007
Same author

Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.

European journal of neurology·2007
Same author

Titin and ryanodine receptor antibodies in myasthenia gravis.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Myasthenia gravis: disease severity and prognosis.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.

Neurology·2006

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Background:

  • Systemic lupus erythematosus (SLE) affects approximately 10% of patients with epileptic seizures.
  • Seizures preceding SLE onset are typically primary generalized.
  • Both epilepsy and SLE may arise from a shared genetic predisposition.

Purpose of the Study:

  • To investigate the relationship between epilepsy, SLE, and IgA deficiency.
  • To explore the genetic links between epilepsy and immune system anomalies.

Main Methods:

  • Observational analysis of patient cohorts with SLE and epilepsy.
  • Association studies with HLA antigens (HLA-A2, HLA-A1, B8).
  • Genetic locus mapping on chromosome 6.

Main Results:

  • Phenytoin treatment can induce reversible IgA deficiency in epileptic patients.
  • Drug-induced IgA deficiency is associated with HLA-A2.
  • Drug-independent IgA deficiency is linked to HLA-A1, B8.
  • The gene for IgA deficiency and epilepsy loci are mapped to chromosome 6 within the HLA complex.

Conclusions:

  • A common genetic susceptibility may link epilepsy and immune disturbances, including IgA deficiency.
  • The HLA complex on chromosome 6 plays a role in the predisposition to both conditions.
  • Understanding these genetic links can inform future research into shared mechanisms and treatments.

Related Experiment Videos